The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phases II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.
 
John K. Chan
No Relationships to Disclose
 
Wei Deng
No Relationships to Disclose
 
Robert Higgins
No Relationships to Disclose
 
Albert J. Bonebrake
No Relationships to Disclose
 
Michael Hicks
No Relationships to Disclose
 
Krishnansu Sujata Tewari
No Relationships to Disclose
 
Stephanie Gaillard
No Relationships to Disclose
 
Pedro T Ramirez
No Relationships to Disclose
 
Bradley J. Monk
Consulting or Advisory Role - Advaxis; Amgen; AstraZeneca; Cerulean Pharma; GlaxoSmithKline; Gradalis; Merck; Roche/Genentech; Tesaro; Verastem
Speakers' Bureau - Roche/Genentech
Research Funding - Amgen (Inst); Array BioPharma (Inst); Genentech (Inst); Janssen (Inst); Lilly (Inst); Novartis (Inst); Tesaro (Inst)